This research suggests that early menopause may itself be a direct risk factor for cognitive decline, even when depression ...

The global frontotemporal dementia market is experiencing robust growth due to the increasing prevalence of neurodegenerative disorders, advancements in diagnostic and therapeutic technologies, and ...

TOKYO – Japan is expected to lower the price of lecanemab, an Alzheimer's drug codeveloped by Japanese drugmaker Eisai Co.

In the fresh study, scientists at the China-Japan Friendship Hospital in Beijing ... according to the findings published in the Alzheimer’s and Dementia journal. Previous research on mice has ...

cDivision of Emergency and Critical Care Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan dDepartment of Anesthesiology ... Since this study replicated the methodology of ...

A person diagnosed with dementia has improved survival outcomes in recent years amid significant progress in dementia diagnosis and care, according to a recent multinational study led by a University ...

Treating the neurodegenerative disease in its earlier stages is key to slowing cognitive decline. A new study offers hope for the future.

A major Japanese study has revealed that drinking at least 600 millilitres of green tea daily could reduce the risk of ...

CheapInsurance.com reports the U.S. can learn from Japan's aging population solutions, from eldercare to inclusive community ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

A collaborative team of researchers has succeeded in revealing the high-resolution structures of amyloid β (Aβ40) fibrils carrying the Tottori-type familial mutation (D7N) by leveraging the ...